N4 Pharma Plc (N4P.L)
Stock analysis · LSE · Healthcare · Drug Manufacturers - Specialty & Generic
Market Cap
N/A
PE (TTM)
N/A
EPS (TTM)
N/A
Dividend Yield
N/A
Beta
0.29
Day Range
N/A
52-wk Range
N/A
Avg Volume
N/A
Volume
N/A
N4 Pharma Plc (N4P.L) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →Proprietary Signals
About N4 Pharma Plc
N4 Pharma Plc is a specialized pharmaceutical company dedicated to creating advanced silica nanoparticle delivery platforms for pharmaceutical and biotechnology organizations throughout the United Kingdom. A core product is Nuvec, a non-viral adjuvant delivery system specifically designed for use in vaccine development and cancer therapies. Founded in 1979, the company is headquartered in London, UK.
Peers
Recent News
- No recent news available.
Related
Browse more tickers: sitemap